Xinfang Xu
- Organic Chemistry top 0.2%
- Cyclopropane Reaction Mechanisms 123
- Catalytic C–H Functionalization Methods 97
- Catalytic Alkyne Reactions 75
- Synthesis and Catalytic Reactions 38
- Synthetic Organic Chemistry Methods 35
- Asymmetric Synthesis and Catalysis 29
- Oxidative Organic Chemistry Reactions 11
- Inorganic Chemistry top 2%
- Asymmetric Hydrogenation and Catalysis 14
- Pharmaceutical Science top 2%
- Process Chemistry and Technology top 10%
- Toxicology top 10%
- Journals
- Journal of the American Chemical Society (8 papers)Angewandte Chemie International Edition (12 papers)Nature Communications (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xinfang Xu
164 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 73
- Organic Chemistry 4.9k
- Inorganic Chemistry 617
- Pharmaceutical Science 219
- Process Chemistry and Technology 29
- Toxicology 31
Countries citing papers authored by Xinfang Xu
This map shows the geographic impact of Xinfang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinfang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinfang Xu more than expected).
Fields of papers citing papers by Xinfang Xu
This network shows the impact of papers produced by Xinfang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinfang Xu. The network helps show where Xinfang Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xinfang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 16 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 29 | |
| 13 | 2021 | 77 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 6 | |
| 16 | 2013 | 69 | |
| 17 | 2013 | 12 | |
| 18 | 2011 | 50 | |
| 19 | 2011 | 58 | |
| 20 | 2010 | 52 |
About Xinfang Xu
Xinfang Xu is a scholar working on Organic Chemistry, Pharmaceutical Science and Inorganic Chemistry, having authored 169 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cyclopropane Reaction Mechanisms (123 papers), Catalytic C–H Functionalization Methods (97 papers), Catalytic Alkyne Reactions (75 papers), Synthesis and Catalytic Reactions (38 papers), Synthetic Organic Chemistry Methods (35 papers), Asymmetric Synthesis and Catalysis (29 papers), Asymmetric Hydrogenation and Catalysis (14 papers) and Oxidative Organic Chemistry Reactions (11 papers). The work is most often cited by research in Organic Chemistry (4.9k citations), Inorganic Chemistry (617 citations) and Pharmaceutical Science (219 citations). Xinfang Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Michael P. Doyle, Wenhao Hu, Peter Y. Zavalij, Lihua Qiu, Yang Zheng, Chao Pei, Kuiyong Dong, Yu Qian, Cheng Zhang and Maxim O. Ratnikov. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.